Skip to main content
. 2022 May 9;13:876306. doi: 10.3389/fimmu.2022.876306

Figure 1.

Figure 1

Survey data from the DigiHero SARS-CoV-2 booster vaccination module. (A) Statistics of participants with prior or planned third SARS-CoV-2 vaccination (booster). (B) Time between completion of the primary vaccination series and third vaccination in months. (C) SARS-CoV-2 third vaccination type. (D) Tolerability of the third vaccination compared to previous SARS-CoV-2 vaccinations. (E) Adverse events upon third vaccination.